Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762

Go back to Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
(NASDAQ: PHIO) Delayed: 1.00 --0 (-0%)
Previous Close $1.00    52 Week High
Open $1.01    52 Week Low
Day High $1.04    P/E N/A 
Day Low $1.00    EPS
Volume 168,582